
    
      This a randomized, double-blind, parallel, single-center, exploratory trial. 60 patients will
      be randomized to two treatments: benzalkonium chloride solution treatment or normal saline
      treatment.The purpose of study is to evaluate the efficacy and safety of benzalkonium
      chloride solution clearing the oral colonized bacterium in hospitalized patients with COPD.
    
  